Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Streamex Corp.BSGM · Entity 1816 | Director | August 15, 2023 | August 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Streamex Corp.
Report date August 15, 2023 · Filed August 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 221,999 |
Reported balance
After 2023-08-15 transaction · row 1
1 source rowRow 1 · 2023-08-15 · Grant · Acquired 16,000 · Balance 221,999 F1: The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 second quarter board fees and shall be fully vested as of August 15, 2023, the date of the grant, based on a closing price of $0.6364 per share on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 second quarter board fees and shall be fully vested as of August 15, 2023, the date of the grant, based on a closing price of $0.6364 per share on such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2023 Filed Aug 18, 2023 18:58 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-23-000877 · ownership.xml · nonDerivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,999 F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 second quarter board fees and shall be fully vested as of August 15, 2023, the date of the grant, based on a closing price of $0.6364 per share on such date. Read SEC document |
| April 20, 2023 Filed Apr 21, 2023 16:31 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 17,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-23-000400 · ownership.xml · nonDerivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,999 F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 first quarter board fees and shall be fully vested as of April 20, 2023, the date of the grant, based on a closing price of $1.32 per share on such date. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 18:38 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-23-000168 · ownership.xml · nonDerivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,455 F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's 2022 fourth quarter board fees and shall be fully vested as of February 24, 2023, the date of the grant, based on a closing price of $1.19 per share on such date. Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 20:03 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 45,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-22-001345 · ownership.xml · nonDerivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,455 F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's third quarter board meeting and shall be fully vested as of November 18, 2022, the date of the grant, based on a closing price of $0.44 per share. Read SEC document |
| December 28, 2021 Filed Apr 25, 2022 17:07 UTC | Streamex Corp. BSGM · Entity 1816 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001185185-22-000489 · ownership.xml · derivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-28 F1 · derivative.exercise_date: The stock options shall be fully vested and exercisable as of December 28, 2021, the date of the grant, subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan and the stock option agreement by and between the Company and the reporting person. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 11:34 UTC | Streamex Corp. BSGM · Entity 1816 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.66 | $0.00 |
DisclosureSEC source: 0001185185-20-000466 · ownership.xml · derivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-04-14 F1 · derivative.exercise_date: The option vested in full on April 14, 2020. Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 14:50 UTC | Streamex Corp. BSGM · Entity 1816 | GrantStock Option (Right to Buy) · Derivative | 29,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001185185-19-001466 · ownership.xml · derivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Underlying: Common Stock · 29,000 shares Expires 2029-10-30 F1 · derivative.exercise_date: The option vested on October 30, 2019. Read SEC document |
| October 16, 2018 Filed Nov 9, 2018 20:17 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-18-001974 · ownership.xml · nonDerivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 F1 · balance_after: On September 10, 2018, BioSig Technologies, Inc. effected a 1-for-2.5 reverse stock split (the "Stock Split"). The number of shares reported have been adjusted for the Stock Split. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 12:37 UTC | Streamex Corp. BSGM · Entity 1816 | PurchaseCommon Stock | 25,000 | $1.42 | $35,500.00 |
DisclosureSEC source: 0001185185-18-000385 · form4-foley030818.xml · nonDerivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,000 Read SEC document |
| November 24, 2017 Filed Nov 28, 2017 21:05 UTC | Streamex Corp. BSGM · Entity 1816 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-17-002507 · form4-foley112817.xml · nonDerivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Read SEC document |
| December 22, 2016 Filed Feb 9, 2017 16:54 UTC | Streamex Corp. BSGM · Entity 1816 | GrantOptions to Purchase Common Stock · Derivative | 25,000 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001185185-17-000233 · form4-foley020917.xml · derivative · entry 1 FOLEY DONALD E · CIK 0001014326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-22 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.